Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
D-Street Buzz: Nifty IT outperforms with Tech Mahindra up 3%; Adlabs Entertainment zooms 10%, realty drags

14h moneycontrol
The Indian benchmark indices are trading on a negative note this Tuesday morning with the Nifty down 7 points, trading at 11,544. The Sensex on the other hand shed 41 points and is trading at 38,237.
500825 AMKD BHRYY 500325 539056 RELIANCE 532617 BRTQY 532715 TCHQY AMTEKAUTO 532218 532832 532755 533278 GITANJALI SOUTHBANK 500470 534816 RIGD 526247 INFRATEL 520066 BRITANNIA CLNDY 503100 RLNIY PREMEXPLQ PHOENIXLTD ADLABS JETAIRWAYS JAYBARMARU TECHM GTJLY TTST TATASTEEL TATLY 520077 COALINDIA IBREALEST

0
Global PE KKR plans to list on Indian bourses

2018-08-14 thehindubusinessline
Global investment firm KKR & Co plans to list its Indian operations in the country following an IPO, making it the first international PE firm to mull such a move. The IPO will exclude the PE firm’s private equity operations, according to a report in The Financial Times.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - ESOP/ESOS/ESPS

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - Updates

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - Updates

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - Shareholders meeting

2018-07-26 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

0
Bharti Infratel Q1, profit dips 4% to Rs 638 cr

2018-07-25 moneycontrol
Mobile tower company Bharti Infratel today reported 4 percent decline in net profit to Rs 638 crore for the first quarter of current fiscal on account of consolidation in the telecom sector. The company had posted net profit of Rs 664 crore in the April-June quarter of last fiscal, 2017-18.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - Outcome of Board Meeting

2018-07-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

1
Ahead of merger with Idea, Vodafone India revenue declines 31.1%

2018-07-25 livemint
Mumbai: Vodafone India’s revenue for the June quarter declined 31.1% to €959 million due to the ongoing tariff war in India’s telecom industry and cuts in interconnection usage charges (IUC) for both domestic and international calls, the company said in a statement on Wednesday. Vodafone Group Plc’s services revenue from its India business stood at €955 million in the quarter, down from €1,385 million in the year-ago period.
BHRYY VOD VOD VODPF 534816 INFRATEL

0
Bharti Infratel Limited - Press Release

2018-07-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

0
Bharti Infratel Limited - Updates

2018-07-25 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
BHRYY 534816 INFRATEL

1
Bharti Infratel, Indus Tower merger deal gets Sebi nod

2018-07-25 livemint
New Delhi: Mobile tower arm of telecom major Bharti Airtel, Infratel on Wednesday said it has received clearance from stock exchanges for its merger with Indus Towers.
532454 BHRYY VOD VOD VODPF 534816 IDEA ICLQY INFRATEL 532822 BHRQY BHARTIARTL

1
Bharti Infratel gets clearance from stock exchanges for Indus Towers deal

2018-07-25 thehindubusinessline
Bharti Infratel, the mobile tower arm of telecom major Bharti Airtel, has received clearance from stock exchanges for its merger with Indus Towers. It will now approach the National Company Law Tribunal for its approval.
532454 BHRYY VOD VOD VODPF 534816 IDEA ICLQY INFRATEL 532822 BHRQY BHARTIARTL

1
Bharti Infratel, Indus Tower merger deal gets bourses#39; nod

2018-07-25 moneycontrol
Mobile tower arm of telecom major Bharti Airtel, Bharti Infratel today said it has received clearance from the BSE and NSE for its merger with Indus Towers. It will now approach National Company Law Tribunal for its approval, the company said.
532454 BHRYY VOD VOD VODPF 534816 IDEA ICLQY INFRATEL 532822 BHRQY BHARTIARTL

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

CUSIP: 00B92P9G4